{"title":"DELIVERY OF EMERGENCY CARE FOR PATIENTS WITH LYMPHOMA IN A DEDICATED FACILITY BY ADVANCED NURSE PRACTITIONERS","authors":"M. Fowler","doi":"10.1002/hon.70093_ON01","DOIUrl":null,"url":null,"abstract":"<p><b>Introduction:</b> Patients with lymphoma often experience acute complications, including infections, disease progression, and treatment-related side effects, necessitating urgent medical attention. Traditional emergency departments may not provide optimal care due to long wait times and a lack of specialist haemato-oncology expertise. To address these challenges, our institution established a dedicated emergency care facility for all patients with cancer, staffed by advanced nurse practitioners (ANPs). This service aims to improve access to timely, expert-driven emergency care while reducing unnecessary hospital admissions.</p><p><b>Methods:</b> The dedicated emergency care facility is staffed by experienced ANPs with specialist haemato-oncology training. All ANPs have a dedicated MSc in Advanced Clinical Practice and the unit also supports trainee ANPs completing their MSc programme. The service operates 7 days per week, providing rapid assessment, symptom management, and coordination with haematology teams. ANPs perform comprehensive patient assessments, prescribe medications (including blood product authorisation), initiate diagnostics, manage acute complications, and determine appropriate interventions, including outpatient treatment, rapid specialist referrals, or hospital admission if necessary. A multidisciplinary approach ensures continuity of care and optimal patient outcomes.</p><p><b>Results:</b> Since its implementation, the service has enhanced the efficiency of emergency care for lymphoma patients. Wait times for assessment have significantly decreased, and hospital admission rates have been reduced by providing timely interventions in an ambulatory setting. The ANP-led model has improved patient satisfaction, with high ratings for accessibility, communication, and symptom management. Additionally, collaboration with haemato-oncology specialists has streamlined patient pathways, ensuring prompt escalation of care when needed.</p><p><b>Conclusions:</b> A dedicated ANP-led emergency care facility provides a safe, efficient, and patient-centered approach to managing lymphoma-related emergencies. This model enhances the quality of care while alleviating pressure on emergency departments. Its success highlights the critical role of ANPs in specialist acute haemato-oncology services, with potential for replication in other cancer centres.</p><p><b>Research</b> <b>funding declaration:</b> Nil</p><p><b>Keywords:</b> outpatient developments and ambulatory care</p><p>No potential sources of conflict of interest.</p>","PeriodicalId":12882,"journal":{"name":"Hematological Oncology","volume":"43 S3","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.70093_ON01","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematological Oncology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hon.70093_ON01","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Patients with lymphoma often experience acute complications, including infections, disease progression, and treatment-related side effects, necessitating urgent medical attention. Traditional emergency departments may not provide optimal care due to long wait times and a lack of specialist haemato-oncology expertise. To address these challenges, our institution established a dedicated emergency care facility for all patients with cancer, staffed by advanced nurse practitioners (ANPs). This service aims to improve access to timely, expert-driven emergency care while reducing unnecessary hospital admissions.
Methods: The dedicated emergency care facility is staffed by experienced ANPs with specialist haemato-oncology training. All ANPs have a dedicated MSc in Advanced Clinical Practice and the unit also supports trainee ANPs completing their MSc programme. The service operates 7 days per week, providing rapid assessment, symptom management, and coordination with haematology teams. ANPs perform comprehensive patient assessments, prescribe medications (including blood product authorisation), initiate diagnostics, manage acute complications, and determine appropriate interventions, including outpatient treatment, rapid specialist referrals, or hospital admission if necessary. A multidisciplinary approach ensures continuity of care and optimal patient outcomes.
Results: Since its implementation, the service has enhanced the efficiency of emergency care for lymphoma patients. Wait times for assessment have significantly decreased, and hospital admission rates have been reduced by providing timely interventions in an ambulatory setting. The ANP-led model has improved patient satisfaction, with high ratings for accessibility, communication, and symptom management. Additionally, collaboration with haemato-oncology specialists has streamlined patient pathways, ensuring prompt escalation of care when needed.
Conclusions: A dedicated ANP-led emergency care facility provides a safe, efficient, and patient-centered approach to managing lymphoma-related emergencies. This model enhances the quality of care while alleviating pressure on emergency departments. Its success highlights the critical role of ANPs in specialist acute haemato-oncology services, with potential for replication in other cancer centres.
Researchfunding declaration: Nil
Keywords: outpatient developments and ambulatory care
期刊介绍:
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.